BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21744170)

  • 1. Coronary artery involvement in cardiac amyloidosis.
    Maska E; Dorman SM; Schofield RS
    Clin Res Cardiol; 2011 Nov; 100(11):1045-6. PubMed ID: 21744170
    [No Abstract]   [Full Text] [Related]  

  • 2. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
    Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
    Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review.
    Tsai SB; Seldin DC; Wu H; O'Hara C; Ruberg FL; Sanchorawala V
    Amyloid; 2011 Sep; 18(3):160-4. PubMed ID: 21504342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restrictive cardiomyopathy caused by cardiac amyloidosis in multiple myeloma].
    Geller JC; Barkow UH; Becher H; Zhou H; Vetter H; Glänzer K
    Internist (Berl); 1992 Jan; 33(1):67-71. PubMed ID: 1551765
    [No Abstract]   [Full Text] [Related]  

  • 5. [A rare cause of cardiopulmonary insufficiency].
    Scheffold N; Rumpelt HJ; Hildt C; Cyran J
    Internist (Berl); 1996 Apr; 37(4):387-91. PubMed ID: 8655276
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical significance of histopathologic patterns of cardiac amyloidosis.
    Smith TJ; Kyle RA; Lie JT
    Mayo Clin Proc; 1984 Aug; 59(8):547-55. PubMed ID: 6748745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow amyloidosis.
    Invernizzi R; Palladini G; Benatti C; Travaglino E; Nuvolone M; Merlini G
    Haematologica; 2006 May; 91(5 Suppl):EIM01. PubMed ID: 16709522
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual case of cardiac amyloidosis.
    Garibaldi B; Zaas D
    J Gen Intern Med; 2007 Jul; 22(7):1047-52. PubMed ID: 17447098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac amyloidosis.
    Nadkar MY; Pandit AP; Bamburde SH; Singh R
    J Assoc Physicians India; 2008 Dec; 56():992-4. PubMed ID: 19322982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac amyloidosis. A case report].
    Butcovan D; Arsenescu C; Pintilie D; Dabija E; Dabija A; Georgescu GI
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):46-9. PubMed ID: 16607826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senile cardiac amyloidosis: Clinical manifestations and non-invasive diagnostic approach.
    Varvarousis D; Polytarchou K; Daskalopoulos N; Mantas I
    Hellenic J Cardiol; 2017; 58(1):60-64. PubMed ID: 28163147
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary cardiac amyloidosis with pathologic hip fracture secondary to bone amyloid.
    Sundar AS; Talwar KK; Chopra P
    Int J Cardiol; 1989 Feb; 22(2):272-4. PubMed ID: 2914750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposition of amyloid proteins in the epicardial coronary arteries of 58 patients with primary systemic amyloidosis.
    Wittich CM; Neben-Wittich MA; Mueller PS; Gertz MA; Edwards WD
    Cardiovasc Pathol; 2007; 16(2):75-8. PubMed ID: 17317539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary amyloidosis AL as a cause of restrictive cardiomyopathy].
    Rückert Y; Hansen A; Dörffel WV; Eckert B; Scholze J
    Z Kardiol; 1997 Oct; 86(10):812-7. PubMed ID: 9454448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histomorphometric analysis of intramyocardial vessels in primary and senile amyloidosis: epicardium versus endocardium.
    Sharma PP; Payvar S; Litovsky SH
    Cardiovasc Pathol; 2008; 17(2):65-71. PubMed ID: 18329550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsuspected amyloidosis and cardiac arrest following mitral valve replacement.
    Schwartz JG; Ghidoni JJ
    Int J Cardiol; 1985 Dec; 9(4):485-7. PubMed ID: 4077305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of AL amyloidosis with 4'-lodo-4'-deoxydoxorubicin: an update.
    Merlini G; Anesi E; Garini P; Perfetti V; Obici L; Ascari E; Lechuga MH; Capri G; Gianni L
    Blood; 1999 Feb; 93(3):1112-3. PubMed ID: 10025983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Restrictive cardiomyopathy secondary to cardiac amyloidosis as the unique manifestation of multiple myeloma].
    Correa-Rotter R; Lobato-Mendizábal E; Labardini-Méndez J; Reyes E
    Rev Invest Clin; 1987; 39(2):167-70. PubMed ID: 3659628
    [No Abstract]   [Full Text] [Related]  

  • 19. Restrictive cardiomyopathy with kappa light chain deposits in myocardium as a complication of multiple myeloma. Histochemical and electron microscopic observations.
    McAllister HA; Seger J; Bossart M; Ferrans VJ
    Arch Pathol Lab Med; 1988 Nov; 112(11):1151-4. PubMed ID: 3140760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial ischemia due to vascular systemic amyloidosis: a quantitative analysis of autopsy findings on stenosis of the intramural coronary arteries.
    Ishikawa Y; Ishii T; Masuda S; Asuwa N; Kiguchi H; Hirai S; Murayama A
    Pathol Int; 1996 Mar; 46(3):189-94. PubMed ID: 10846569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.